Blog

The EndBrainCancer Initiative Receives CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site.

The Wizard201G clinical trial from Boston Biomedical Inc. is a vaccine treatment for patients with recurrent or progressive GBM following initial treatment. Pacific Neuroscience Institute is a site for this phase 2 study which is currently recruiting. Contact us for eligibility criteria at 310-582-7460.

Check out Pacific Neuroscience Institute's advanced clinical trials line up for May 2018. PNI is very excited to announce a new clinical trial for the assessment and treatment of patients with newly diagnosed glioblastoma. Find out how Dr. Santosh Kesari's protocol tackles brain cancer treatment in a whole new way.

Dr. Santosh Kesari's new clinical trial approaches glioblastoma treatment in a whole new way. By giving immunotherapy first rather than radiation and chemotherapy, the patient's immune system remains uncompromised which could result in better responses and lead to better patient outcomes.

Pacific Neuroscience Institute is pleased to announce a new clinical trial for traumatic brain injury patients who have been suffering from chronic motor deficits for more than a year. This study is currently enrolling patients. Clinical trials help bring much needed treatments and therapies to market. Find out more about PNI trials for treatment of primary brain tumors such as glioblastoma, metastatic brain tumors that arise from cancers affecting the breast, lung or skin, quality and outcomes research and other neurological studies.

Pacific Neuroscience Institute opens a novel stem cell therapy clinical trial, which delivers stem cells for brain recovery after traumatic brain injury (TBI) in people who have had chronic motor deficits for over a year following TBI. Read about this groundbreaking trial.

Clinical trials  are an essential way to move the field of medicine forward. Our team at Pacific Neuroscience Institute reviews and adds new trials for treatment of primary brain tumors such as glioblastoma multiforme (GBM) and metastatic brain tumors that arise from cancers affecting the breast, lung or skin.

The past year at Pacific Neuroscience Institute was one of amazing growth and transformational milestones. Read about what we have accomplished and what lies ahead in 2018 including a new clinic and novel clinical trials.

Pacific Neuroscience Institute offers advanced clinical trials for primary brain tumors like glioblastoma multiforme, as well as cancers that have metastasized to the brain from primary cancers such as breast, prostate, and melanoma. Read more.

Featured at the SoCal Biomedical Conference in September 2017, Drs. Chester Griffiths and Santosh Kesari highlight Pacific Neuroscience Institute's unique collaborative approach to research and patient care.